The Global Vaccine Safety Initiative: Enhancing vaccine pharmacovigilance capacity at country level
dc.contributor.author | Maure, C.G. | |
dc.contributor.author | Dodoo, A.N. | |
dc.contributor.author | Bonhoefer, J. | |
dc.contributor.author | Zuber, P.L.F. | |
dc.date.accessioned | 2018-11-23T09:04:27Z | |
dc.date.available | 2018-11-23T09:04:27Z | |
dc.date.issued | 2014-09 | |
dc.description.abstract | Large-scale immunization programmes now extend to all parts of the world, in- cluding least developed countries, where they reach unprecedented numbers of people. e number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people have access to immunization services. Development of immunization pro- grammes in low- and middle-income countries (LMICs) has increased im- munization coverage, which in turn has led to a reduction in vaccine-preventable diseases. However, as vaccine use has increased in LMICs, so has public atten- tion to vaccine safety issues, as happened previously in high-income countries. is has created additional vulnerabil- ity for all immunization programmes. Whether or not they are well founded, concerns about serious adverse events following immunization may rapidly undermine public condence and be- come a serious threat to eective vacci- nation strategies, eroding the enormous gains in disease control achieved with decades of eort. (PDF) The Global Vaccine Safety Initiative: Enhancing vaccine pharmacovigilance capacity at country level. Available from: https://www.researchgate.net/publication/267929878_The_Global_Vaccine_Safety_Initiative_Enhancing_vaccine_pharmacovigilance_capacity_at_country_level [accessed Nov 23 2018]. | en_US |
dc.identifier.other | DOI: 10.2471/BLT.14.138875} | |
dc.identifier.other | Vol. 92(9): pp 695-6 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/25712 | |
dc.language.iso | en | en_US |
dc.publisher | Bulletin of the World Health Organization | en_US |
dc.subject | Global Vaccine | en_US |
dc.subject | pharmacovigilance | en_US |
dc.subject | Safety Initiative | en_US |
dc.subject | immunization | en_US |
dc.title | The Global Vaccine Safety Initiative: Enhancing vaccine pharmacovigilance capacity at country level | en_US |
dc.type | Other | en_US |
Files
Original bundle
1 - 1 of 1
- Name:
- The Global Vaccine Safety Initiative Enhancing vaccine pharmacovigilance capacity at country level.pdf
- Size:
- 707.56 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: